Product Explainer

Fluticasone furoate, umeclidinium and vilanterol once-daily single inhaler triple therapy

Description

In this Product Explainer, Respiratory Physician Dr Adrian Barnett explains the role of fluticasone furoate, umeclidinium and vilanterol once-daily single inhaler triple therapy for the maintenance treatment of asthma in adult patients who are not adequately controlled with an ICS+LABA (5 mins).

This educational activity was developed by Healthed at the request of and with funding from GSK.

PM-AU-FVU-PPTX-230007 Approved July 2023.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Daryl Efron

A/Prof Daryl Efron

Autism – A Primer for GPs

Prof Ernest Somerville

Prof Ernest Somerville

Epilepsy & Driving – Navigating the Grey Areas

Prof Adrian Esterman

Prof Adrian Esterman

COVID & Bird Flu Update – New Variants, New Vax Schedule, Antivirals

Dr Mark Hohenberg

Dr Mark Hohenberg

MCI - What Can GPs do About it?

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Adrian Barnett

expert

Dr Adrian Barnett

Respiratory Physician, Gold Coast University Hospital

Date published: 17 July 2023